U.S. Markets open in 20 mins

A Second Baby Died In A Gene Therapy Study — Slugging This Biotech Stock

ALLISON GATLIN
A Second Baby Died In A Gene Therapy Study — Slugging This Biotech Stock

A second baby reportedly died in a study of Novartis' gene therapy, Zolgensma — sending shares of biotech Regenxbio into free fall Monday. Regenxbio lost nearly 8% by the closing bell.